Table 3.

Deletion analysis of clone SB19

Type	Sequence	% binding
FL	MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREPLVQEVEDVDEGLVQDLHGVVAGLLDPVEKLLTDWFKKFKNVSKDCKMTFYLEMYDWSGGCKLG	85
C1	MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREPLVQEVEDVDEGLVQDLHGVVAGLLDPVEKLLTDWFKKFKNVS MMSGGCKLG	87
C2	MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREPLVQEVEDVDEGLVQDLHGVVAGLLDPVE MMSGGCKLG	88
C3	MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREPLVQEVEDVDEGLVQ MMSGGCKLG	89
C4	MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREP MMSGGCKLG	88
M1	MDEKTTGWRGGHVVEGLAGELEQLRARLEHHGAGQREP MMSGGCKLG	0.065
N1	MD GHVVEGLAGELEQLRARLEHHPQGQREP MMSGGCKLG	69
N2	MD EGLAGELEQLRARLEHHPQGQREPLVQEVEDVDEGLVQDLHGVVAGLLDPVEKLLTDWFKKFKNVSKDCKMTFYLEMYDWSGGCKLG	30
N3	M ELEQLRARLEHHPQGQREP MMSGGCKLG	0.058

The full-length (FL), C-terminal deleted (C1–C4), N-terminal deleted (N1–N3), and point mutated (M1) peptide sequences are shown. The “% binding” refers to the performance of these peptides in the SA column-binding assay.